Nu Skin Enterprises (NYSE:NUS) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Nu Skin Enterprises (NYSE:NUS) posted its earnings results on Wednesday. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.05 by $0.04, Briefing.com reports. The company had revenue of $417.31 million during the quarter, compared to the consensus estimate of $426.55 million. Nu Skin Enterprises had a net margin of 0.44% and a return on equity of 10.73%. The firm’s revenue for the quarter was down 13.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.37 earnings per share.

Nu Skin Enterprises Stock Performance

NUS stock traded up $0.12 during midday trading on Thursday, reaching $12.54. 347,028 shares of the company’s stock traded hands, compared to its average volume of 724,981. The firm has a market capitalization of $619.73 million, a PE ratio of 70.56 and a beta of 1.13. The company has a 50-day moving average price of $12.66 and a two-hundred day moving average price of $15.89. Nu Skin Enterprises has a 52 week low of $11.73 and a 52 week high of $38.23. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.28 and a current ratio of 2.13.

Nu Skin Enterprises Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 6th. Investors of record on Monday, February 26th were issued a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 1.91%. The ex-dividend date was Friday, February 23rd. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 133.34%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. DA Davidson decreased their target price on shares of Nu Skin Enterprises from $15.50 to $12.50 and set a “neutral” rating for the company in a research report on Thursday. StockNews.com downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. Four analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $20.83.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.